Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where N. Tanaka is active.

Publication


Featured researches published by N. Tanaka.


European Urology Supplements | 2010

143 NADIR PSA AND TIME TO PSA PROGRESSION PREDICT OVERALL SURVIVAL IN PATIENTS WITH METASTATIC PROSTATE CANCER

A. Tomioka; N. Tanaka; M. Miyake; T. Inoue; S. Anai; T. Ikeda; Kiyohide Fujimoto; Yoshihiko Hirao; N. Konishi


European Urology Supplements | 2018

Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of alpha-1 adrenoceptor antagonist alone vs. combination with cyclooxygenase-2 inhibitor

N. Tanaka; K. Torimoto; I. Asakawa; M. Miyake; S. Anai; Y. Nakai; T. Fujii; M. Hasegawa; Kiyohide Fujimoto


European Urology Supplements | 2018

Genitourinary and gastrointestinal toxicity in patients undergoing prostate low-dose-rate brachytherapy

Y. Morizawa; N. Tanaka; I. Asakawa; S. Hori; Y. Nakai; M. Miyake; S. Anai; H. Masatoshi; Kiyohide Fujimoto


European Urology Supplements | 2018

Urinary nerve growth factor and brain-derived neurotrophic factor can predict therapeutic efficacy in children with monosymptomatic nocturnal enuresis

Y. Morizawa; K. Aoki; S. Hori; Y. Nakai; M. Miyake; S. Onishi; N. Tanaka; Kiyohide Fujimoto


European Urology Supplements | 2017

The hybrid method can cover an extensive area of planning target volume compared with the conventional method in prostate cancer patients who undergo low-dose-rate brachytherapy

N. Tanaka; I. Asakawa; Y. Nakai; M. Miyake; S. Anai; T. Fujii; M. Hasegawa; N. Konishi; Kiyohide Fujimoto


European Urology Supplements | 2014

1046 Comparison of overall survival between the life expectancy and the estimated outcome in patients who underwent radical nephrectomy for renal cell carcinoma

N. Tanaka; M. Miyake; T. Inoue; S. Anai; Y. Chihara; Yoshihiko Hirao; Kiyohide Fujimoto


European Urology Supplements | 2013

456 Comparison of overall survival between the life expectancy and the estimated outcome in patients who underwent radical nephrectomy or partial nephrectomy for renal cell carcinoma

N. Tanaka; Yoshihiko Hirao; Kiyohide Fujimoto


European Urology Supplements | 2010

1008 THE PHOSPHORYLATION STATUS OF FADD IN BIOPSY SPECIMENS IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE OF PROSTATE CANCER AFTER PROSTATECTOMY

T. Ikeda; N. Tanaka; K. Shimada; Y. Matsumura; M. Miyake; S. Anai; T. Tomioka; E. Okajima; Kiyohide Fujimoto; N. Konishi; Yoshihiko Hirao


European Urology Supplements | 2009

974 THE PHOSPHORYLATION STATUS OF FADD IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY

T. Ikeda; N. Tanaka; K. Shimada; Y. Matsumura; M. Miyake; S. Anai; A. Tomioka; E. Okajima; Kiyohide Fujimoto; N. Konishi


European Urology Supplements | 2009

969 CAN PREOPERATIVE CLINICOPATHOLOGICAL PARAMETERS BE THE PREDICTOR OF THE POSTOPERATIVE BIOCHEMICAL RECURRENCE IN THE PATIENTS WHO RECEIVED RADICAL PROSTATECTOMY

N. Tanaka; S. Anai; E. Okajima; Kiyohide Fujimoto; Yoshihiko Hirao; N. Konishi

Collaboration


Dive into the N. Tanaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge